Benzoxazine compound, curable resin composition, adhesive, adhesive film, cured product, circuit board, interlayer insulating material, and multilayer printed wiring board

By using a benzooxazine compound with a specific structure in the curable resin composition, combining an aliphatic skeleton with 4 or more carbon atoms and a benzooxazine ring, flexibility and dielectricity in the curable resin composition are solved by combining aliphatic skeleton with 4 or more carbon atoms, and a benzooxazine ring. The problem of taking into account both characteristics has achieved multiple excellent performance before and after curing.

CN112533906BActive Publication Date: 2024-11-05SEKISUI CHEMICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980051984.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-09-14
Filing Date
2019-07-23
Publication Date
2024-11-05
Estimated Expiration
2039-07-23

AI Technical Summary

Technical Problem

The conventional curable resin composition is difficult to take into account both the flexibility before curing and the dielectric properties after curing, and especially the interlayer insulating material of the printed wiring board, there is a problem that the dielectric properties are excellent but the flexibility is insufficient.

Method used

The benzoxazine compound with a diamine or triamine residue with an aliphatic backbone having a carbon atom number of 4 or more and a benzoxazine ring is used to improve flexibility before curing and optimize it by combining with the curable resin composition. Dielectric properties after curing.

Benefits of technology

It realizes a curable resin composition with excellent flexibility before curing and excellent dielectric properties after curing. It is suitable for applications such as multi-layer printed wiring boards and provides better adhesion and dielectric properties.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0002933887360000051
    Figure BDA0002933887360000051
  • Figure BDA0002933887360000052
    Figure BDA0002933887360000052
  • Figure BDA0002933887360000061
    Figure BDA0002933887360000061
Patent Text Reader

Abstract

The object of the present invention is to provide a benzoxazine compound that can be used for a curable resin composition having excellent flexibility before curing and excellent dielectric properties after curing. In addition, the object of the present invention is to provide a curable resin composition containing the benzoxazine compound, an adhesive, an adhesive film, a cured product, a circuit board, an interlayer insulating material and a multilayer printed wiring board using the curable resin composition. The benzoxazine compound of the present invention has a diamine residue having an aliphatic skeleton having 4 or more carbon atoms and / or a triamine residue having an aliphatic skeleton having 4 or more carbon atoms in the molecule, and a benzoxazine ring.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a benzoxazine compound that can be used in a curable resin composition having excellent flexibility before curing and excellent dielectric properties after curing. In addition, the present invention relates to a curable resin composition containing the benzoxazine compound, an adhesive, an adhesive film, a cured product, a circuit board, an interlayer insulating material, and a multilayer printed wiring board using the curable resin composition. Background Art

[0002] Low shrinkage and excellent adhesiveness, insulation and chemical resistance epoxy resins are used in a large number of industrial products. Especially for the curable resin composition used in the interlayer insulating material of printed wiring board, it is necessary to have dielectric properties such as low dielectric constant and low dielectric loss tangent. As such excellent curable resin composition of dielectric properties, for example, in patent documentation 1 and 2, a curable resin composition containing curable resin and a compound with a specific structure as a curing agent is disclosed. However, such curable resin composition has the problem of being difficult to take into account the flexibility before curing and the dielectric properties after curing.

[0003] Prior art literature

[0004] Patent Literature:

[0005] Patent Document 1: Japanese Patent Application Publication No. 2017-186551

[0006] Patent Document 2: International Publication No. 2016 / 114286 Summary of the invention

[0007] Problems to be solved by the invention

[0008] An object of the present invention is to provide a benzoxazine compound that can be used in a curable resin composition having excellent flexibility before curing and excellent dielectric properties after curing. Another object of the present invention is to provide a curable resin composition containing the benzoxazine compound, and an adhesive, an adhesive film, a cured product, a circuit board, an interlayer insulating material, and a multilayer printed wiring board using the curable resin composition.

[0009] Means for solving problems

[0010] The present invention is a benzoxazine compound having a diamine residue having an aliphatic skeleton having 4 or more carbon atoms and / or a triamine residue having an aliphatic skeleton having 4 or more carbon atoms, and a benzoxazine ring in a molecule.

[0011] Hereinafter, the present invention will be described in detail.

[0012] The present inventors have found that a curable resin composition having excellent flexibility before curing and excellent dielectric properties after curing can be obtained by using a benzoxazine compound having a specific structure, thereby completing the present invention.

[0013] The benzoxazine compound of the present invention has in the molecule: a diamine residue having an aliphatic skeleton having 4 or more carbon atoms (hereinafter, also referred to as a "diamine residue") and / or a triamine residue having an aliphatic skeleton having 4 or more carbon atoms (hereinafter, also referred to as a "triamine residue"). Since the benzoxazine compound of the present invention has the above-mentioned diamine residue and / or the above-mentioned triamine residue, when it is formulated into a curable resin composition, the flexibility of the curable resin composition before curing can be improved. In addition, by making the benzoxazine compound of the present invention have the above-mentioned diamine residue and / or the above-mentioned triamine residue and have a benzoxazine ring, the dielectric properties of the cured product of the obtained curable resin composition such as low dielectric constant and low dielectric loss tangent are excellent.

[0014] In addition, in this specification, the said "residue" refers to the structure of the part other than the functional group provided for bonding, For example, "diamine residue" refers to the structure of the part other than the amino group in the raw material diamine.

[0015] The lower limit of the number of carbon atoms in the aliphatic skeleton of the diamine residue and the triamine residue is 4. By setting the number of carbon atoms in the aliphatic skeleton of the diamine residue and the triamine residue to 4 or more, the obtained curable resin composition has excellent flexibility before curing and excellent dielectric properties after curing. The preferred lower limit of the number of carbon atoms in the aliphatic skeleton of the diamine residue and the triamine residue is 7, and the more preferred lower limit is 8.

[0016] The upper limit of the number of carbon atoms in the aliphatic skeleton of the diamine residue and the triamine residue is preferably not particularly limited, but is substantially 90.

[0017] The aliphatic skeleton of the above-mentioned diamine residue and the above-mentioned triamine residue may be substituted.

[0018] When the aliphatic skeleton of the diamine residue and the triamine residue is substituted, examples of the substituent include a halogen atom, an aryl group, an alkoxy group, a nitro group, and a cyano group.

[0019] As the diamine serving as a source of the above-mentioned diamine residue, an aliphatic diamine can be used.

[0020] Examples of the aliphatic diamine include aliphatic diamines derived from dimer acids, linear or branched aliphatic diamines, aliphatic ether diamines, alicyclic diamines, etc. Among them, aliphatic diamines derived from dimer acids are preferred.

[0021] Examples of the aliphatic diamine derived from the dimer acid include dimer diamines derived from dimer acids which are dimers of aliphatic acids having 10 to 30 carbon atoms, such as oleic acid, linoleic acid, linolenic acid, palmitoleic acid, and elaidic acid, and hydrogenated dimer diamines thereof.

[0022] Examples of the linear or branched aliphatic diamine include 1,4-butanediamine, 1,6-hexanediamine, 1,8-octanediamine, 1,9-nonanediamine, 1,10-decanediamine, 1,11-undecanediamine, 1,12-dodecanediamine, 1,14-tetradecanediamine, 1,16-hexadecanediamine, 1,18-octadecanediamine, 1,20-eicosanediamine, 2-methyl-1,8-octanediamine, 2-methyl-1,9-nonanediamine, and 2,7-dimethyl-1,8-octanediamine.

[0023] Examples of the aliphatic ether diamine include 2,2′-oxybis(ethylamine), 3,3′-oxybis(propylamine), and 1,2-bis(2-aminoethoxy)ethane.

[0024] Examples of the alicyclic diamine include 1,3-bis(aminomethyl)cyclohexane, 1,4-bis(aminomethyl)cyclohexane, cyclohexanediamine, methylcyclohexanediamine, and isophoronediamine.

[0025] As the diamine from which the diamine residue is derived, a diamine obtained by reaction of the aliphatic diamine with an acid dianhydride and having an acid dianhydride residue in the main chain and amino groups derived from the aliphatic diamine at both terminals may be used.

[0026] Examples of the acid dianhydride include pyromellitic anhydride, 3,3'-oxydiphthalic anhydride, 3,4'-oxydiphthalic anhydride, 4,4'-oxydiphthalic anhydride, 4,4'-(4,4'-isopropyldiphenoxy)diphthalic anhydride, 4,4'-bis(2,3-dicarboxyphenoxy)diphenyl ether dianhydride, p-phenylenebis(trimellitic acid monoester anhydride), 2,3,3',4'-biphenyltetracarboxylic anhydride, etc. Among them, 4,4'-(4,4'-isopropyldiphenoxy)diphthalic anhydride is preferred.

[0027] As the triamine serving as a source of the triamine residue, an aliphatic triamine can be used.

[0028] Examples of the aliphatic triamine include aliphatic triamines derived from trimer acids, linear or branched aliphatic triamines, etc. Among them, aliphatic triamines derived from the trimer acids are preferred.

[0029] Examples of the aliphatic triamine derived from the trimer acid include trimer triamines derived from trimer acids which are trimers of aliphatic acids having 10 to 30 carbon atoms, such as oleic acid, linoleic acid, linolenic acid, palmitoleic acid, and elaidic acid, and hydrogenated trimer triamines thereof.

[0030] Examples of the linear or branched aliphatic triamine include 3,3'-diamino-N-methyldipropylamine, 3,3'-diaminodipropylamine, diethylenetriamine, bis(hexamethylene)triamine, and 2,2'-bis(methylamino)-N-methyldiethylamine.

[0031] The aliphatic triamine may be used in the form of a mixture with the aliphatic diamine.

[0032] As a commercial item of the said aliphatic diamine and / or the said aliphatic triamine, the aliphatic diamine and / or aliphatic triamine manufactured by BASF, the aliphatic diamine and / or aliphatic triamine manufactured by Croda, etc. are mentioned, for example.

[0033] Examples of the aliphatic diamine and / or aliphatic triamine manufactured by BASF include Versamine 551 and Versamine 552.

[0034] Examples of the aliphatic diamine and / or aliphatic triamine manufactured by Croda include Priamine 1071, Priamine 1073, Priamine 1074, and Priamine 1075.

[0035] The benzoxazine compound of the present invention preferably has a structure represented by the following formula (1-1) or (1-2), the following formula (2-1) or (2-2), or the following formula (3) as a structure including the diamine residue and / or the triamine residue and the benzoxazine ring. By having a structure represented by the following formula (1-1) or (1-2), the following formula (2-1) or (2-2), or the following formula (3), the benzoxazine compound of the present invention has better flexibility before curing and better dielectric properties after curing.

[0036]

Chemical formula 1

[0037]

[0038] In the formula (1-1), A is the above-mentioned diamine residue, and X and X' are each independently a hydrogen atom or an arbitrary substituent.

[0039] In formula (1-2), A is the above-mentioned triamine residue, and X, X' and X" are each independently a hydrogen atom or an arbitrary substituent.

[0040]

Chemical formula 2

[0041]

[0042] In formula (2-1), A is the above-mentioned diamine residue, B and B' are each independently any organic group, R and R' are each independently a hydrogen atom or any substituent, B and each R can be bonded to form a ring structure, B' and each R' can be bonded to form a ring structure, and Y and Y' are each independently a hydrogen atom or any substituent.

[0043] In formula (2-2), A is the above-mentioned triamine residue, B, B' and B" are each independently an arbitrary organic group, R, R' and R" are each independently a hydrogen atom or an arbitrary substituent, B and each R can be bonded to form a ring structure, B' and each R' can be bonded to form a ring structure, B" and each R" can be bonded to form a ring structure, and Y, Y' and Y" are each independently a hydrogen atom or an arbitrary substituent.

[0044]

Chemical formula 3

[0045]

[0046] In formula (3), A and A' are each independently the above-mentioned diamine residue, B is an arbitrary organic group, R and R' are each independently a hydrogen atom or an arbitrary substituent, B and R can be bonded to form a ring structure, B and R' can be bonded to form a ring structure, and X and X' are each independently a hydrogen atom or an arbitrary substituent.

[0047] When X and X' in the above formula (1-1), and X, X' and X" in the above formula (1-2) are substituents, examples of the substituents include halogen atoms, linear or branched alkyl groups, linear or branched alkenyl groups, alicyclic groups, aryl groups, alkoxy groups, nitro groups, cyano groups and the like.

[0048] When X and X' in the above formula (1-1) and X, X' and X" in the above formula (1-2) are substituents, the hydrogen atoms in the aromatic ring may be substituted with a plurality of the substituents.

[0049] When Y and Y' in the above formula (2-1) and Y, Y' and Y" in the above formula (2-2) are substituents, examples of the substituents include linear or branched alkyl groups, linear or branched alkenyl groups, alicyclic groups, aryl groups, and phenyl groups having alkyl groups or alkoxy groups as substituents.

[0050] When Y and Y' in the above formula (2-1) and Y, Y' and Y" in the above formula (2-2) are substituents, the hydrogen atoms in the aromatic ring may be substituted with a plurality of the substituents.

[0051] It is preferred that B and each R, and B' and each R' in the above formula (2-1), and B and each R, B' and each R', and B" and each R" in the above formula (2-2) form a ring structure. The above ring structure is preferably an imide ring.

[0052] In particular, the structure represented by the above formula (2-1) is preferably a structure represented by the following formula (4).

[0053]

Chemical formula 4

[0054]

[0055] In formula (4), A is the above-mentioned diamine residue, C and C' are acid dianhydride residues, and Y and Y' are each independently a hydrogen atom or an arbitrary substituent.

[0056] When Y and Y' in the above formula (4) are substituents, examples of the substituent include linear or branched alkyl groups, linear or branched alkenyl groups, alicyclic groups, aryl groups, and phenyl groups having alkyl groups or alkoxy groups as substituents.

[0057] When Y and Y' in the above formula (4) are substituents, the hydrogen atoms in the aromatic ring may be substituted with a plurality of the substituents.

[0058] Examples of the acid dianhydride that is a source of the acid dianhydride residue represented by C and C′ in the formula (4) include the same acid dianhydride as that used in the reaction between the aliphatic diamine and the acid dianhydride.

[0059] When X and X' in the above formula (3) are substituents, examples of the substituents include halogen atoms, linear or branched alkyl groups, linear or branched alkenyl groups, alicyclic groups, aryl groups, alkoxy groups, nitro groups, cyano groups, and the like.

[0060] When X and X' in the above formula (3) are substituents, the hydrogen atoms in the aromatic ring may be substituted with a plurality of the substituents.

[0061] It is preferred that B and R, and B and R' in the above formula (3) form a ring structure. The above ring structure is preferably an imide ring.

[0062] In particular, as the structure represented by the above formula (3), a structure represented by the following formula (5) is preferred.

[0063]

Chemical formula 5

[0064]

[0065] In formula (5), A and A' are each independently the above-mentioned diamine residue, C is an acid dianhydride residue, and X and X' are each independently a hydrogen atom or an arbitrary substituent.

[0066] When X and X' in the above formula (5) are substituents, examples of the substituents include halogen atoms, linear or branched alkyl groups, linear or branched alkenyl groups, alicyclic groups, aryl groups, alkoxy groups, nitro groups, cyano groups, and the like.

[0067] When X and X' in the above formula (5) are substituents, the hydrogen atoms in the aromatic ring may be substituted with a plurality of the substituents.

[0068] The benzoxazine compound of the present invention also preferably has a repeating structural unit represented by the following formula (6), the following formula (7) or the following formula (8) as a structure including the above-mentioned diamine residue and the above-mentioned benzoxazine ring. By having a repeating structural unit represented by the following formula (6), the following formula (7) or the following formula (8), the benzoxazine compound of the present invention has better flexibility before curing and better dielectric properties and mechanical strength after curing.

[0069]

Chemical formula 6

[0070]

[0071] In formula (6), A is the above-mentioned diamine residue, and Z is a bonding bond or an arbitrary organic group. A part or all of the hydrogen atoms in the aromatic ring in formula (6) may be substituted with an arbitrary substituent.

[0072]

Chemical formula 7

[0073]

[0074] In formula (7), A is the above-mentioned diamine residue, B and B' are each independently any organic group, R and R' are each independently a hydrogen atom or any substituent, B and R can be bonded to form a ring structure, B' and R' can be bonded to form a ring structure, and W is any organic group.

[0075]

Chemical formula 8

[0076]

[0077] In formula (8), A and A' are each independently the above-mentioned diamine residue, B is an arbitrary organic group, R and R' are each independently a hydrogen atom or an arbitrary substituent, B and R may be bonded to form a ring structure, B and R' may be bonded to form a ring structure, and Z is a bonding bond or an arbitrary organic group. A part or all of the hydrogen atoms of the aromatic ring in formula (8) may be substituted by an arbitrary substituent.

[0078] When the hydrogen atom of the aromatic ring in the above formula (6) is substituted by an arbitrary substituent, examples of the substituent include a halogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, an alicyclic group, an aryl group, an alkoxy group, a nitro group, a cyano group and the like.

[0079] W in the above formula (7) is preferably the above diamine residue or a diamine residue not having an aliphatic skeleton having 4 or more carbon atoms.

[0080] In the above formula (7), B and each R, and B' and each R' preferably form a ring structure. The above ring structure is preferably an imide ring.

[0081] When the hydrogen atom of the aromatic ring in the above formula (8) is substituted by an arbitrary substituent, examples of the substituent include a halogen atom, a linear or branched alkyl group, a linear or branched alkenyl group, an alicyclic group, an aryl group, an alkoxy group, a nitro group, a cyano group and the like.

[0082] It is preferred that B and R, and B and R' in the above formula (8) form a ring structure. The above ring structure is preferably an imide ring.

[0083] The preferred lower limit of the molecular weight of the benzoxazine compound of the present invention is 300, and the preferred upper limit is 200,000. By setting the molecular weight within this range, when the benzoxazine compound of the present invention is used in a curable resin composition, the obtained curable resin composition has better flexibility before curing and better dielectric properties of the cured product. The more preferred lower limit of the molecular weight of the benzoxazine compound of the present invention is 400, and the more preferred upper limit is 100,000.

[0084] It should be noted that in this specification, for compounds with determined molecular structures, the above-mentioned "molecular weight" is the molecular weight obtained according to the structural formula, but for compounds with a wide distribution of polymerization degree and compounds with uncertain modified sites, the above-mentioned "molecular weight" is sometimes represented by the number average molecular weight. In this specification, the above-mentioned "number average molecular weight" is measured using gel permeation chromatography (GPC) using tetrahydrofuran as a solvent, and the value obtained by polystyrene conversion. As the column used when measuring the number average molecular weight converted based on polystyrene by GPC, for example, JAIGEL-2H-A (Japan Analysis Industry Co., Ltd.) etc. can be cited.

[0085] Examples of methods for producing the benzoxazine compound having the structure represented by the above formula (1-1) or (1-2) among the benzoxazine compounds of the present invention include a method of reacting the above diamine or triamine, a monofunctional phenol compound and paraformaldehyde.

[0086] Examples of the monofunctional phenol compound include phenol, o-cresol, m-cresol, p-cresol, 2,3-dimethylphenol, 2,4-dimethylphenol, 2,5-dimethylphenol, 2,6-dimethylphenol, 2-ethylphenol, 3-ethylphenol, 4-ethylphenol, 4-tert-butylphenol, p-octylphenol, p-cumylphenol, dodecylphenol, o-phenylphenol, p-phenylphenol, 1-naphthol, 2-naphthol, m-methoxyphenol, p-methoxyphenol, m-ethoxyphenol, p-ethoxyphenol, 3,4-dimethylphenol, and 3,5-dimethylphenol. Among these, phenol is preferred.

[0087] These monofunctional phenol compounds may be used alone or in combination of two or more.

[0088] Examples of methods for producing the benzoxazine compound having a structure represented by the above formula (2-1) or (2-2) among the benzoxazine compounds of the present invention include the following methods.

[0089] That is, first, the diamine or triamine is reacted with an acid dianhydride in a twice-molar amount thereof to obtain an amide oligomer having anhydride groups at all terminals. The obtained amide oligomer having anhydride groups at all terminals is reacted with 3-aminophenol in a twice-molar amount thereof to obtain an amide oligomer having phenolic hydroxyl groups at all terminals. A method of reacting the obtained amide oligomer having phenolic hydroxyl groups at all terminals and a monoamine compound with paraformaldehyde, etc.

[0090] Examples of the monoamine compound include aniline, o-toluidine, m-toluidine, p-toluidine, 2,3-dimethylaniline, 2,4-dimethylaniline, 2,5-dimethylaniline, 3,4-dimethylaniline, 3,5-dimethylaniline, 2-tert-butylaniline, 3-tert-butylaniline, 4-tert-butylaniline, 1-naphthylamine, 2-naphthylamine, 1-aminoanthracene, 2-aminoanthracene, 9-aminoanthracene, 1-aminopyrene, 3-chloroaniline, o-methoxyaniline, m-methoxyaniline, p-methoxyaniline, 1-amino-2-methylnaphthalene, 4-ethylaniline, 4-ethynylaniline, 4-isopropylaniline, and 4-(methylthio)aniline. Among these, aniline is preferred.

[0091] Examples of methods for producing the benzoxazine compound having the structure represented by the above formula (3) among the benzoxazine compounds of the present invention include the following methods.

[0092] Specifically, first, an acid dianhydride is reacted with a 2-fold molar amount of the above diamine to obtain an oligoimide having amino groups at both ends, and then the obtained oligoimide having amino groups at both ends, a monofunctional phenol compound and paraformaldehyde are reacted.

[0093] Examples of a method for producing the benzoxazine compound having the structure represented by the above formula (6) among the benzoxazine compounds of the present invention include a method of reacting the above diamine or bifunctional phenol compound with paraformaldehyde.

[0094] Examples of the bifunctional phenol compound include 2,2-bis(4-hydroxy-3,5-dimethylphenyl)propane, 2,2-bis(4-hydroxy-3-methylphenyl)propane, 2,2-bis(4-hydroxyphenyl)butane, 1,1-bis(4-hydroxyphenyl)cyclohexane, 2,2-bis(4-hydroxyphenyl)hexafluoropropane, 2,2-bis(4-hydroxyphenyl)hexafluoropropane, 4,4′-dihydroxydiphenyl sulfone, 2-hydroxyphenyl ether, 1,1-bis(4-hydroxyphenyl)ethane, 1,1-bis(4-hydroxyphenyl)-1-phenylethane, 1,3-bis(2-(4-hydroxyphenyl)-2)propyl)benzene, and 1,4-bis(2-(4-hydroxyphenyl)-2)propyl)benzene.

[0095] In the method for producing the benzoxazine compound having the structure represented by the above formula (6), a monofunctional phenol compound may be used together with the above-mentioned bifunctional phenol compound.

[0096] As the monofunctional phenol compound, the same monofunctional phenol compound as that used in the method for producing the benzoxazine compound having a structure represented by the above formula (1-1) or (1-2) can be used.

[0097] Examples of methods for producing the benzoxazine compound having the structure represented by the above formula (7) among the benzoxazine compounds of the present invention include the following methods.

[0098] That is, first, the above-mentioned diamine is reacted with an acid dianhydride in a 2-fold molar amount thereof to obtain an amide oligomer having an anhydride group at both ends. The obtained amide oligomer having an anhydride group at both ends is reacted with 3-aminophenol in a 2-fold molar amount thereof to obtain an amide oligomer having phenolic hydroxyl groups at both ends. A method of reacting the obtained amide oligomer having phenolic hydroxyl groups at both ends, the above-mentioned diamine (a diamine having an aliphatic skeleton having 4 or more carbon atoms) or a diamine not having an aliphatic skeleton having 4 or more carbon atoms, with paraformaldehyde, etc.

[0099] Examples of the diamine not having an aliphatic skeleton having 4 or more carbon atoms include 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 4,4'-diaminodiphenyl ether, o-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 3,3'-diaminodiphenyl sulfone, 4,4'-diaminodiphenyl sulfone, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenoxy)benzene, bis[4-(4-aminophenoxy)phenyl]methane, 2,2-bis[4 -(4-aminophenoxy)phenyl]propane, 1,3-bis[2-(4-aminophenyl)-2-propyl]benzene, 1,4-bis[2-(4-aminophenyl)-2-propyl]benzene, 3,3'-diamino-4,4'-dihydroxyphenylmethane, 4,4'-diamino-3,3'-dihydroxyphenylmethane, 3,3'-diamino-4,4'-dihydroxyphenyl ether, bisaminophenylfluorene, bistoluidinefluorene, 4,4'-bis(4-aminophenoxy)biphenyl, 4,4'-diamino-3,3'-dihydroxyphenyl ether, 3,3'-diamino-4,4'-dihydroxybiphenyl, 4,4'-diamino-2,2'-dihydroxybiphenyl, and the like.

[0100] Examples of methods for producing the benzoxazine compound having the structure represented by the above formula (8) among the benzoxazine compounds of the present invention include the following methods.

[0101] Specifically, first, an acid dianhydride is reacted with a 2-fold molar amount of the above diamine to obtain an oligoimide having amino groups at both ends, and then the obtained oligoimide having amino groups at both ends, a bifunctional phenol compound and paraformaldehyde are reacted.

[0102] As the bifunctional phenol compound, the same bifunctional phenol compound as that used in the method for producing the benzoxazine compound having the structure represented by the above formula (6) can be used.

[0103] In the method for producing the benzoxazine compound having the structure represented by the above formula (8), a monofunctional phenol compound may be used together with the above-mentioned bifunctional phenol compound.

[0104] As the monofunctional phenol compound, the same monofunctional phenol compound as that used in the method for producing the benzoxazine compound having a structure represented by the above formula (1-1) or (1-2) can be used.

[0105] The reaction for forming the benzoxazine ring of the benzoxazine compound of the present invention can be carried out in a solvent or without a solvent. When the reaction is carried out in a solvent, examples of the reaction solvent used include aromatic non-polar solvents and halogen solvents.

[0106] Examples of the aromatic nonpolar solvent include benzene, toluene, xylene, pseudocumene, and mesitylene.

[0107] Examples of the halogen solvent include chloroform and dichloromethane.

[0108] Among them, toluene and xylene are preferred, and toluene is more preferred, since they have little burden on the environment and human body, are highly versatile, and are inexpensive.

[0109] The above solvents may be used alone or in combination of two or more.

[0110] When the aromatic nonpolar solvent is used as the reaction solvent, alcohols may be used together with the aromatic nonpolar solvent.

[0111] The alcohols are not particularly limited, but alcohols having a boiling point lower than that of the aromatic nonpolar solvents are preferred.

[0112] Examples of such alcohols include alcohols having a carbon number of 4 or less. Among them, methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, and isobutanol are preferred.

[0113] These alcohols may be used alone or in combination of two or more.

[0114] During the reaction, the reaction solvent may be refluxed. In the reaction for producing the benzoxazine compound, water is generated in the reaction system. The water, like alcohols, has the effect of inhibiting the synthesis reaction of the benzoxazine compound by solvation. When a solvent that azeotropes with water is used as a synthetic solvent, in order to make the reaction proceed efficiently, the water generated in the reaction may be distilled out of the system by azeotropy. At this time, for example, the water generated in the reaction may be distilled out by using an isobaric dropping funnel with a stopcock, a Dimrot condenser, a Dean-Stark apparatus, or the like.

[0115] In the reaction for forming the benzoxazine ring of the benzoxazine compound of the present invention, a heating treatment is performed during synthesis. Examples of the heating treatment method include a method of raising the temperature to a predetermined temperature using a temperature controller such as an oil bath and then maintaining the temperature constant.

[0116] The predetermined temperature during the heating treatment is not particularly limited, but is preferably adjusted so that the temperature of the reaction solution is 50° C. to 150° C. By setting the temperature of the reaction solution to 50° C. or higher, the synthesis reaction of the benzoxazine compound can be prevented from being slowed down, thereby improving the synthesis efficiency. By setting the temperature of the reaction solution to 150° C. or lower, the gelation of the reaction solution during the synthesis reaction can be suppressed.

[0117] The duration of the above-mentioned heating treatment is not particularly limited, and it is preferably continued for about 1 to 10 hours after the start of heating. By making the duration of the above-mentioned heating treatment longer than 1 hour, the synthesis reaction can be fully carried out and the synthesis yield can be improved. By making the duration of the above-mentioned heating treatment shorter than 10 hours, the gelation of the reaction solution and the insolubilization of the benzoxazine compound as the synthetic product can be suppressed.

[0118] After the heating treatment is completed, the reaction medium may be released from the temperature regulator such as an oil bath to be cooled, or the reaction medium may be cooled using a refrigerant or the like.

[0119] Examples of a method for removing the benzoxazine compound from the reaction solution after cooling include a poor solvent reprecipitation method, a concentration solidification method (removal of the solvent by distillation under reduced pressure), and a spray drying method.

[0120] A curable resin composition containing the benzoxazine compound of the present invention is also one of the present invention.

[0121] The curable resin composition of the present invention contains the benzoxazine compound of the present invention, so that it has excellent flexibility before curing and excellent dielectric properties after curing.

[0122] The curable resin composition of the present invention is preferably a curable resin composition containing a curable resin, a curing agent, and the benzoxazine compound of the present invention.

[0123] The preferred lower limit of the content of the benzoxazine compound of the present invention in 100 parts by weight of the total of the curable resin, the curing agent and the benzoxazine compound of the present invention is 5 parts by weight, and the preferred upper limit is 80 parts by weight. By setting the content of the benzoxazine compound of the present invention to be within this range, the flexibility before curing and the dielectric properties after curing of the obtained curable resin composition are more excellent. The more preferred lower limit of the content of the benzoxazine compound of the present invention is 10 parts by weight, and the more preferred upper limit is 60 parts by weight.

[0124] The curable resin composition of the present invention may contain, in addition to the benzoxazine compound of the present invention, another benzoxazine compound other than the benzoxazine compound of the present invention, within a range not hindering the purpose of the present invention.

[0125] As the curable resin, epoxy resin, cyanate resin, phenolic resin, imide resin, maleimide resin, silicone resin, acrylic resin, fluororesin, etc. can be cited. Among them, the curable resin preferably includes at least one selected from epoxy resin, cyanate resin, phenolic resin, imide resin and maleimide resin, and more preferably includes epoxy resin. The curable resin can be used alone or in combination of two or more.

[0126] Examples of the epoxy resin include bisphenol A epoxy resin, bisphenol F epoxy resin, bisphenol E epoxy resin, bisphenol S epoxy resin, 2,2'-diallylbisphenol A epoxy resin, hydrogenated bisphenol epoxy resin, propylene oxide-added bisphenol A epoxy resin, resorcinol epoxy resin, biphenyl epoxy resin, sulfide epoxy resin, diphenyl ether epoxy resin, dicyclopentadiene epoxy resin, naphthalene epoxy resin, fluorene epoxy resin, naphthylene ether epoxy resin, phenol novolac epoxy resin, o-cresol novolac epoxy resin, dicyclopentadiene novolac epoxy resin, biphenyl novolac epoxy resin, naphthol novolac epoxy resin, glycidylamine epoxy resin, alkyl polyol epoxy resin, rubber-modified epoxy resin, and glycidyl ester compounds.

[0127] Examples of the curing agent include phenolic curing agents, thiol curing agents, amine curing agents, acid anhydride curing agents, cyanate curing agents, and active ester curing agents, among which phenolic curing agents and active ester curing agents are preferred.

[0128] The preferred lower limit of the content of the curing agent in 100 parts by weight of the total of the curable resin, the curing agent and the benzoxazine compound of the present invention is 5 parts by weight, and the preferred upper limit is 80 parts by weight. By making the content of the curing agent within this range, the curability and storage stability of the obtained curable resin composition are more excellent. The more preferred lower limit of the content of the curing agent is 10 parts by weight, and the more preferred upper limit is 60 parts by weight.

[0129] The curable resin composition of the present invention preferably contains a curing accelerator. By containing the curing accelerator, the curing time can be shortened and the productivity can be improved.

[0130] Examples of the curing accelerator include imidazole-based curing accelerators, tertiary amine-based curing accelerators, phosphine-based curing accelerators, photobase generators, and sulfonium salt-based curing accelerators. Among them, imidazole-based curing accelerators are preferred from the viewpoint of curability and storage stability.

[0131] The above-mentioned curing accelerators may be used alone or in combination of two or more.

[0132] The preferred lower limit of the content of the curing accelerator is 0.8 parts by weight relative to 100 parts by weight of the total of the curable resin, the curing agent and the benzoxazine compound of the present invention. When the content of the curing accelerator is 0.8 parts by weight or more, the effect of shortening the curing time is more excellent. The more preferred lower limit of the content of the curing accelerator is 1 part by weight.

[0133] From the viewpoint of adhesiveness and the like, the upper limit of the content of the curing accelerator is preferably 10 parts by weight, and more preferably 5 parts by weight.

[0134] The curable resin composition of the present invention preferably contains an inorganic filler.

[0135] By containing the above-mentioned inorganic filler, the curable resin composition of the present invention has further excellent moisture absorption reflow resistance and plating resistance while maintaining excellent adhesiveness and the like.

[0136] The inorganic filler is preferably at least one of silica and barium sulfate. By containing at least one of silica and barium sulfate as the inorganic filler, the curable resin composition of the present invention has better moisture absorption reflow resistance and plating resistance.

[0137] Examples of other inorganic fillers other than the above-mentioned silica and the above-mentioned barium sulfate include alumina, aluminum nitride, boron nitride, silicon nitride, glass powder, glass frit, glass fiber, carbon fiber, and inorganic ion exchangers.

[0138] The above-mentioned inorganic fillers may be used alone or in combination of two or more.

[0139] The preferred lower limit of the average particle size of the inorganic filler is 50 nm, and the preferred upper limit is 4 μm. By setting the average particle size of the inorganic filler to this range, the coating property of the obtained curable resin composition is more excellent. The more preferred lower limit of the average particle size of the inorganic filler is 100 nm, and the more preferred upper limit is 3 μm.

[0140] The preferred lower limit of the content of the inorganic filler is 50 parts by weight and the preferred upper limit is 500 parts by weight relative to 100 parts by weight of the total of the curable resin, the curing agent and the benzoxazine compound of the present invention. By setting the content of the inorganic filler to be within this range, the moisture absorption reflow resistance and plating resistance of the obtained curable resin composition are further improved. The more preferred lower limit of the content of the inorganic filler is 100 parts by weight.

[0141] The curable resin composition of the present invention may contain a flow control agent for the purpose of improving the coating property to an adherend and the shape retention property in a short time.

[0142] Examples of the flow control agent include fumed silica such as AEROSIL, and layered silicate.

[0143] The above-mentioned flow regulators may be used alone or in combination of two or more.

[0144] In addition, as the above-mentioned flow control agent, it is preferable to use a flow control agent having an average particle size of less than 100 nm.

[0145] The preferred lower limit of the content of the flow regulator is 0.1 parts by weight, and the preferred upper limit is 50 parts by weight, relative to 100 parts by weight of the total of the curable resin, the curing agent, and the benzoxazine compound of the present invention. By making the content of the flow regulator within this range, the effects of improving the coating property and shape retention of the adherend in a short time are more excellent. The more preferred lower limit of the content of the flow regulator is 0.5 parts by weight, and the more preferred upper limit is 30 parts by weight.

[0146] The curable resin composition of the present invention may contain an organic filler for the purpose of relaxing stress, imparting toughness, and the like.

[0147] Examples of the organic filler include silicone rubber particles, acrylic rubber particles, urethane rubber particles, polyamide particles, polyamideimide particles, polyimide particles, benzoguanamine particles, and core-shell particles thereof, etc. Among them, polyamide particles, polyamideimide particles, and polyimide particles are preferred.

[0148] The above-mentioned organic fillers may be used alone or in combination of two or more.

[0149] The preferred upper limit of the content of the organic filler is 300 parts by weight relative to 100 parts by weight of the total of the curable resin, the curing agent, and the benzoxazine compound of the present invention. When the content of the organic filler is 300 parts by weight or less, the toughness of the cured product of the obtained curable resin composition is further improved while maintaining excellent adhesion. The more preferred upper limit of the content of the organic filler is 200 parts by weight.

[0150] The curable resin composition of the present invention may contain a flame retardant.

[0151] Examples of the flame retardant include boehmite aluminum hydroxide, aluminum hydroxide, metal hydrates such as magnesium hydroxide, halogen compounds, phosphorus compounds, nitrogen compounds, etc. Among them, boehmite aluminum hydroxide is preferred.

[0152] The above flame retardants may be used alone or in combination of two or more.

[0153] The preferred lower limit of the content of the flame retardant is 5 parts by weight, and the preferred upper limit is 200 parts by weight, relative to 100 parts by weight of the total of the curable resin, the curing agent, and the benzoxazine compound of the present invention. By setting the content of the flame retardant to be within this range, the obtained curable resin composition has excellent flame retardancy while maintaining excellent adhesion and the like. The more preferred lower limit of the content of the flame retardant is 10 parts by weight, and the more preferred upper limit is 150 parts by weight.

[0154] The curable resin composition of the present invention may contain a thermoplastic resin within the range that does not hinder the purpose of the present invention. By using the above-mentioned thermoplastic resin, the curable resin composition of the present invention has better flow characteristics, is easier to take into account both filling properties and anti-leaching properties during thermal compression bonding, and has better bending resistance after curing.

[0155] Examples of the thermoplastic resin include polyimide resins, phenoxy resins, polyamide resins, polyamideimide resins, and polyvinyl acetal resins. Among these, phenoxy resins are preferred from the viewpoint of heat resistance and handling properties.

[0156] The above-mentioned thermoplastic resins may be used alone or in combination of two or more.

[0157] The preferred lower limit of the number average molecular weight of the thermoplastic resin is 3000, and the preferred upper limit is 100,000. By making the number average molecular weight of the thermoplastic resin within this range, the flow characteristics of the obtained curable resin composition and the bending resistance after curing are more excellent. The more preferred lower limit of the number average molecular weight of the thermoplastic resin is 5000, and the more preferred upper limit is 50,000.

[0158] The preferred lower limit of the content of the thermoplastic resin is 2 parts by weight, and the preferred upper limit is 60 parts by weight, relative to 100 parts by weight of the total of the curable resin, the curing agent, and the benzoxazine compound of the present invention. By making the content of the thermoplastic resin more than 2 parts by weight, the flow characteristics of the obtained curable resin composition and the bending resistance after curing are more excellent. By making the content of the thermoplastic resin less than 60 parts by weight, the adhesion and heat resistance of the obtained curable resin composition are more excellent. The more preferred lower limit of the content of the thermoplastic resin is 3 parts by weight, and the more preferred upper limit is 50 parts by weight.

[0159] The curable resin composition of the present invention may contain a solvent from the viewpoint of coating properties and the like.

[0160] As the above-mentioned solvent, from the viewpoint of coating properties, storage stability, etc., a nonpolar solvent having a boiling point of 160° C. or lower or an aprotic polar solvent having a boiling point of 160° C. or lower is preferred.

[0161] Examples of the nonpolar solvent having a boiling point of 160° C. or lower or the aprotic polar solvent having a boiling point of 160° C. or lower include ketone solvents, ester solvents, hydrocarbon solvents, halogen solvents, ether solvents, and nitrogen-containing solvents.

[0162] Examples of the ketone solvent include acetone, methyl ethyl ketone, methyl isobutyl ketone, and cyclohexanone.

[0163] Examples of the ester solvent include methyl acetate, ethyl acetate, isobutyl acetate, and the like.

[0164] Examples of the hydrocarbon solvent include benzene, toluene, n-hexane, isohexane, cyclohexane, methylcyclohexane, and n-heptane.

[0165] Examples of the halogen-based solvent include dichloromethane, chloroform, and trichloroethylene.

[0166] Examples of the ether solvent include diethyl ether, tetrahydrofuran, 1,4-dioxane, and 1,3-dioxolane.

[0167] Examples of the nitrogen-containing solvent include acetonitrile and the like.

[0168] Among them, from the viewpoints of handling properties and solubility of the curing agent, at least one selected from a ketone solvent having a boiling point of 60° C. or higher, an ester solvent having a boiling point of 60° C. or higher, and an ether solvent having a boiling point of 60° C. or higher is preferred. Examples of such a solvent include methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, ethyl acetate, isobutyl acetate, 1,4-dioxane, 1,3-dioxolane, and tetrahydrofuran.

[0169] In addition, the above-mentioned "boiling point" means a value measured under the condition of 101 kPa, or a value converted to 101 kPa using a boiling point conversion chart or the like.

[0170] The preferred lower limit of the content of the above-mentioned solvent in the curable resin composition of the present invention is 15% by weight, and the preferred upper limit is 80% by weight. By making the content of the above-mentioned solvent within this range, the coating properties of the curable resin composition of the present invention are more excellent. The more preferred lower limit of the content of the above-mentioned solvent is 20% by weight, and the more preferred upper limit is 70% by weight.

[0171] The curable resin composition of the present invention may contain a reactive diluent within a range not hindering the purpose of the present invention.

[0172] As the reactive diluent, a reactive diluent having two or more reactive functional groups in one molecule is preferred from the viewpoint of adhesion reliability.

[0173] The curable resin composition of the present invention may further contain additives such as a coupling agent, a dispersant, a storage stabilizer, an anti-bleeding agent, a flux, and a leveling agent.

[0174] Examples of a method for producing the curable resin composition of the present invention include a method of mixing a curable resin, a curing agent, the benzoxazine compound of the present invention, and a solvent or the like as needed using a mixer such as a homodispersor, a universal mixer, a Banbury mixer, or a kneader.

[0175] The curable resin composition of the present invention is applied onto a substrate film and dried to obtain a curable resin composition film containing the curable resin composition of the present invention, and the curable resin composition film can be cured to obtain a cured product.

[0176] A cured product obtained by curing the curable resin composition of the present invention is also one of the present invention.

[0177] The preferred upper limit of the dielectric loss tangent of the cured product of the curable resin composition of the present invention at 23°C is 0.0045. By setting the dielectric loss tangent of the cured product at 23°C to this range, the curable resin composition of the present invention can be preferably used for interlayer insulating materials such as multilayer printed wiring boards. The more preferred upper limit of the dielectric loss tangent of the cured product at 23°C is 0.0040, and the further preferred upper limit is 0.0035.

[0178] It should be noted that the above-mentioned "dielectric loss tangent" is a value measured under the condition of 1.0 GHz using a dielectric constant measuring device and a network analyzer. It should be noted that the cured product used to measure the above-mentioned "dielectric loss tangent" can be obtained by heating the above-mentioned curable resin composition film having a thickness of 40 to 200 μm at 190° C. for 90 minutes.

[0179] The curable resin composition of the present invention can be used in a wide range of applications, for example, adhesives for printed wiring boards, adhesives for cover layers of flexible printed circuit boards, copper-clad laminates, adhesives for semiconductor bonding, interlayer insulating materials, prepregs, sealants for LEDs, adhesives for structural materials, and the like.

[0180] Among them, it is preferably used for adhesive applications. An adhesive comprising the curable resin composition of the present invention is also one of the present invention.

[0181] The curable resin composition film can be preferably used as an adhesive film. An adhesive film formed using the curable resin composition of the present invention is also one of the present invention.

[0182] Furthermore, a circuit board having the cured product of the present invention is also one of the present invention.

[0183] The curable resin composition of the present invention can be preferably used as an interlayer insulating material for multilayer printed wiring boards, etc., because its cured product has low dielectric constant and low dielectric loss tangent and excellent dielectric properties. An interlayer insulating material made of the curable resin composition of the present invention is also one of the present invention.

[0184] In addition, a multilayer printed wiring board comprising a circuit board, a plurality of insulating layers arranged on the circuit board, and a metal layer arranged between the plurality of insulating layers, wherein the insulating layers comprise a cured product of the interlayer insulating material of the present invention is also one of the present invention.

[0185] Effects of the Invention

[0186] According to the present invention, a benzoxazine compound that can be used in a curable resin composition having excellent flexibility before curing and excellent dielectric properties after curing can be provided. In addition, according to the present invention, a curable resin composition containing the benzoxazine compound, an adhesive, an adhesive film, a cured product, a circuit board, an interlayer insulating material, and a multilayer printed wiring board using the curable resin composition can be provided. DETAILED DESCRIPTION

[0187] Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.

[0188] (Synthesis Example 1 (Preparation of benzoxazine compound A))

[0189] In a 500 mL flask equipped with a reflux tube, an isobaric dropping funnel with a stopcock, and a Dimrot condenser, 150 mL of toluene and 50 mL of methanol were added at once as a mixed solvent at 25° C. and mixed. Next, 18.8 g (0.2 mol) of phenol (manufactured by Tokyo Chemical Industry Co., Ltd.) and 56.2 g (0.1 mol) of Priamine 1074 (manufactured by Croda Co., Ltd.) as a hydrogenated dimer diamine were added at once to the flask at 25° C. and mixed. Then, 13.2 g (0.44 mol) of paraformaldehyde (manufactured by Tokyo Chemical Industry Co., Ltd.) was added at once to the flask at 25° C. and mixed to obtain a mixed solution.

[0190] The flask containing the obtained mixed solution was immersed in an oil bath set at 120° C. and heated under reflux to allow the reaction to proceed. One hour after the start of reflux, the water generated in the reaction system was distilled out of the system by azeotroping with toluene and methanol.

[0191] After the reaction was allowed to proceed for 4 hours from the start of distillation, the flask was removed from the oil bath and the resulting reaction solution was cooled to 25° C. After cooling, the reaction solution was poured into 1 L of methanol to precipitate the reactant. The precipitated solid was dried under reduced pressure to obtain benzoxazine compound A.

[0192] It should be noted that through 1 H-NMR, GPC and FT-IR analysis confirmed that benzoxazine compound A contained a benzoxazine compound having the structure represented by the above formula (1-1) (A was a hydrogenated dimer diamine residue, and X and X' were hydrogen atoms). In addition, the number average molecular weight of benzoxazine compound A was 800.

[0193] (Synthesis Example 2 (Preparation of benzoxazine compound B))

[0194] Benzoxazine compound B was obtained in the same manner as in Synthesis Example 1 except that 56.8 g (0.1 mol) of Priamine 1073 (manufactured by Croda Corporation) as a dimer diamine was used instead of Priamine 1074.

[0195] It should be noted that through 1 H-NMR, GPC and FT-IR analysis confirmed that benzoxazine compound B contained a benzoxazine compound having a structure represented by formula (1-1) (A is a dimer diamine residue, X and X' are hydrogen atoms). In addition, the number average molecular weight of benzoxazine compound B was 800.

[0196] (Synthesis Example 3 (Preparation of benzoxazine compound C))

[0197] Benzoxazine compound C was obtained in the same manner as in Synthesis Example 1 except that 61.7 g (0.1 mol) of Priamine 1071 (manufactured by Croda Corporation) which is a mixture of a dimer diamine and a trimer triamine was used instead of Priamine 1074.

[0198] It should be noted that through 1 H-NMR, GPC and FT-IR analysis confirmed that the benzoxazine compound C contained a benzoxazine compound having a structure represented by the above formula (1-1) (A is a dimer diamine residue, X and X' are hydrogen atoms). In addition, it was confirmed that the benzoxazine compound C contained a benzoxazine compound having a structure represented by the above formula (1-2) (A is a trimer triamine residue, X, X' and X" are hydrogen atoms). In addition, the number average molecular weight of the benzoxazine compound C was 850.

[0199] (Synthesis Example 4 (Preparation of benzoxazine compound D))

[0200] 56.8 g (0.1 mol) of Priamine 1073 (manufactured by Croda) as a dimer diamine was dissolved in 400 g of N-methylpyrrolidone (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., "NMP"). 104.1 g (0.2 mol) of 4,4'-(4,4'-isopropyldiphenoxy)diphthalic anhydride (manufactured by Tokyo Chemical Industry Co., Ltd.) as an aromatic tetracarboxylic acid was added to the obtained solution, and stirred at 25°C for 2 hours to react to obtain an amic acid oligomer solution. After N-methylpyrrolidone was removed from the obtained amic acid oligomer solution under reduced pressure, the solution was heated at 300°C for 2 hours to obtain an imide oligomer having anhydride groups at both ends.

[0201] 26.8 g (0.2 mol) of 3-aminophenol (manufactured by Tokyo Chemical Industry Co., Ltd.) was dissolved in 400 g of N-methylpyrrolidone (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., "NMP"). 157.3 g (0.1 mol) of an amide oligomer having anhydride groups at both ends was added to the obtained solution, and the mixture was stirred at 25° C. for 2 hours to react to obtain an amide oligomer solution. After N-methylpyrrolidone was removed from the obtained amide oligomer solution under reduced pressure, the mixture was heated at 300° C. for 2 hours to obtain an amide oligomer having phenolic hydroxyl groups at both ends.

[0202] In a 500 mL flask equipped with a reflux tube, an isobaric dropping funnel with a stopcock, and a Dimrot condenser, 150 mL of toluene and 50 mL of methanol were added as a mixed solvent at 25° C. at once and mixed. Next, 174.7 g (0.1 mol) of an imide oligomer having phenolic hydroxyl groups at both ends and 18.6 g (0.2 mol) of aniline (manufactured by Tokyo Chemical Industry Co., Ltd.) were added to the flask at once at 25° C. and mixed. Then, 13.2 g (0.44 mol) of paraformaldehyde (manufactured by Tokyo Chemical Industry Co., Ltd.) was added to the flask at once at 25° C. and mixed to obtain a mixed solution.

[0203] The flask containing the obtained mixed solution was immersed in an oil bath set at 120° C. and heated under reflux to allow the reaction to proceed. One hour after the start of reflux, the water generated in the reaction system was distilled out of the system by azeotroping with toluene and methanol.

[0204] After the reaction was allowed to proceed for 4 hours from the start of distillation, the flask was removed from the oil bath and the resulting reaction solution was cooled to 25° C. After cooling, the reaction solution was poured into 1 L of methanol to precipitate the reactant. The precipitated solid was dried under reduced pressure to obtain benzoxazine compound D.

[0205] It should be noted that through 1H-NMR, GPC and FT-IR analysis confirmed that the benzoxazine compound D contained a benzoxazine compound having a structure represented by the above formula (4) (A is a dimer diamine residue, C and C' are 4,4'-(4,4'-isopropyldiphenoxy)diphthalic anhydride residues, and Y and Y' are phenyl groups). In addition, the number average molecular weight of the benzoxazine compound D was 2000.

[0206] (Synthesis Example 5 (Preparation of benzoxazine compound E))

[0207] 113.6 g (0.2 mol) of Priamine 1073 (manufactured by Croda) as a dimer diamine was dissolved in 400 g of N-methylpyrrolidone (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd., "NMP"). 52.0 g (0.1 mol) of 4,4'-(4,4'-isopropyldiphenoxy)diphthalic anhydride (manufactured by Tokyo Chemical Industry Co., Ltd.) as an aromatic tetracarboxylic acid was added to the obtained solution, and stirred at 25°C for 2 hours to react to obtain an amic acid oligomer solution. After N-methylpyrrolidone was removed from the obtained amic acid oligomer solution under reduced pressure, it was heated at 300°C for 2 hours to obtain an imide oligomer having amino groups at both ends.

[0208] In a 500 mL flask equipped with a reflux tube, an isobaric dropping funnel with a stopcock, and a Dimrot condenser, 150 mL of toluene and 50 mL of methanol were added as a mixed solvent at 25° C. at once and mixed. Next, 18.8 g (0.2 mol) of phenol (manufactured by Tokyo Chemical Industry Co., Ltd.) and 160.7 g (0.1 mol) of the obtained imide oligomer having amino groups at both ends were added to the flask at once at 25° C. and mixed. Then, 13.2 g (0.44 mol) of paraformaldehyde (manufactured by Tokyo Chemical Industry Co., Ltd.) was added to the flask at once at 25° C. and mixed to obtain a mixed solution.

[0209] The flask containing the obtained mixed solution was immersed in an oil bath set at 120° C. and heated under reflux to allow the reaction to proceed. One hour after the start of reflux, the water generated in the reaction system was distilled out of the system by azeotroping with toluene and methanol.

[0210] After the reaction was allowed to proceed for 4 hours from the start of distillation, the flask was removed from the oil bath and the resulting reaction solution was cooled to 25° C. After cooling, the reaction solution was poured into 1 L of methanol to precipitate the reactant. The precipitated solid was dried under reduced pressure to obtain benzoxazine compound E.

[0211] It should be noted that through 1H-NMR, GPC and FT-IR analysis confirmed that the benzoxazine compound E contained a benzoxazine compound having a structure represented by the above formula (5). In the benzoxazine compound E, A and A' in the above formula (5) were oligoimide residues having amino groups at both ends, C was a 4,4'-(4,4'-isopropyldiphenoxy)diphthalic anhydride residue, and X and X' were hydrogen atoms. In addition, the number average molecular weight of the benzoxazine compound E was 1960.

[0212] (Synthesis Example 6 (Preparation of benzoxazine compound F))

[0213] In a 500 mL flask equipped with a reflux tube, an isobaric dropping funnel with a stopcock, and a Dimrot condenser, 150 mL of toluene and 50 mL of methanol were added as a mixed solvent at 25° C. at once and mixed. Next, 34.7 g (0.1 mol) of 1,3-bis(2-(4-hydroxyphenyl)-2-propyl)benzene (manufactured by Tokyo Chemical Industry Co., Ltd., "bisphenol M") and 56.2 g (0.1 mol) of Priamine 1074 (manufactured by Croda Co., Ltd.) as a hydrogenated dimer diamine were added at once to the flask at 25° C. and mixed. Then, 13.2 g (0.44 mol) of paraformaldehyde (manufactured by Tokyo Chemical Industry Co., Ltd.) was added at once to the flask at 25° C. and mixed to obtain a mixed solution.

[0214] The flask containing the obtained mixed solution was immersed in an oil bath set at 80° C. and heated under reflux to allow the reaction to proceed. One hour after the start of reflux, the water generated in the reaction system was distilled out of the system by azeotroping with toluene and methanol.

[0215] After the reaction was allowed to proceed for 4 hours from the start of distillation, the flask was removed from the oil bath and the resulting reaction solution was cooled to 25° C. After cooling, the reaction solution was poured into 1 L of methanol to precipitate the reactant. The precipitated solid was dried under reduced pressure to obtain benzoxazine compound F.

[0216] It should be noted that through 1 H-NMR, GPC and FT-IR analysis confirmed that the benzoxazine compound F contained a benzoxazine compound having a repeating structural unit represented by the above formula (6) (A was a hydrogenated dimer diamine residue, and Z was a group represented by the following formula (9)). In addition, the number average molecular weight of the benzoxazine compound F was 12,000.

[0217]

Chemical formula 9

[0218]

[0219] In formula (9), * is the bonding position.

[0220] (Synthesis Example 7 (Preparation of benzoxazine compound G))

[0221] Benzoxazine compound G was obtained in the same manner as in Synthesis Example 1 except that 29.2 g (0.1 mol) of 1,3-bis(3-aminophenoxy)benzene (manufactured by MITSUI FINE CHEMICALS, “APB-N”) which is a diamine having no aliphatic skeleton having 4 or more carbon atoms was used instead of Priamine 1074.

[0222] It should be noted that through 1 H-NMR, GPC and FT-IR analysis confirmed that the benzoxazine compound G contained a benzoxazine compound in which the portion corresponding to A in the above formula (1-1) was a 1,3-bis(3-aminophenoxy)benzene residue and the portions corresponding to X and X' were hydrogen atoms. In addition, the number average molecular weight of the benzoxazine compound G was 600.

[0223] (Examples 1 to 7, Comparative Examples 1 and 2)

[0224] Methyl ethyl ketone as a solvent was added to the materials having the blending ratios described in Table 1, and stirred at 1200 rpm for 4 hours using a stirrer to obtain a curable resin composition. The composition in Table 1 describes the solid content excluding the solvent.

[0225] The obtained curable resin composition was applied to the release treated surface of a PET film ("XG284" manufactured by Toray Industries, Ltd., thickness 25 μm) using an applicator. Then, the film was dried in a 100° C. Gill oven for 5 minutes to volatilize the solvent, thereby obtaining an uncured laminated film having a PET film and a curable resin composition layer having a thickness of 40 μm on the PET film.

[0226] <Evaluation>

[0227] The following evaluations were performed on each of the uncured laminated films obtained in Examples and Comparative Examples.

[0228] (flexibility)

[0229] Each uncured laminated film obtained in the examples and comparative examples was cut into a rectangle of 10 cm in length and 5 cm in width. The film was bent 90 degrees or 180 degrees so that the PET film layer was on the inside, and then restored to a flat state, and the state of the film was visually confirmed. It should be noted that when bent at 180 degrees, it is easier to break than when bent at 90 degrees.

[0230] The case where there was no crack when bent at either 90 degrees or 180 degrees was marked as "○", the case where there was crack when bent at 180 degrees and no crack when bent at 90 degrees was marked as "△", and the case where there was crack when bent at either 90 degrees or 180 degrees was marked as "×" to evaluate the flexibility.

[0231] (Dielectric properties)

[0232] Each uncured laminated film obtained in the embodiment and the comparative example was cut into a size of 2 mm in width and 80 mm in length. The substrate PET film was peeled off from the curable resin composition layer of the cut uncured laminated film, and 5 layers of curable resin composition layers were overlapped using a laminator to obtain a laminate having a thickness of about 200 μm. The obtained laminate was heated at 190 ° C for 90 minutes to obtain a cured body. For the obtained cured body, a cavity resonance perturbation method dielectric constant measuring device CP521 (manufactured by Kanto Electronics Application Development Co., Ltd.) and a network analyzer N5224A PNA (manufactured by Keysight Technologies) were used to measure the dielectric loss tangent at a frequency of 1.0 GHz at 23 ° C using the cavity resonance method.

[0233] The dielectric properties were evaluated by recording the dielectric loss tangent of 0.0035 or less as "◎", the dielectric loss tangent of more than 0.0035 and less than 0.0040 as "○", the dielectric loss tangent of more than 0.0040 and less than 0.0045 as "△", and the dielectric loss tangent of more than 0.0045 as "×".

[0234] (Desmearing property (removability of residue at the bottom of the guide hole))

[0235] (1) Lamination and semi-curing treatment

[0236] The two sides of the CCL substrate (manufactured by Hitachi Chemical Co., Ltd., "E679FG") were immersed in a copper surface roughening agent (manufactured by MEC, "MECetchBOND CZ-8100") to roughen the copper surface. The uncured laminated films obtained in the examples and comparative examples were arranged on both sides of the CCL substrate from the curable resin composition layer side, and laminated on both sides of the CCL substrate using a diaphragm vacuum laminator (manufactured by Meiki Seisakusho, "MVLP-500") to obtain an uncured laminated sample A. Lamination was performed by reducing the pressure for 20 seconds to make the air pressure below 13 hPa, and then pressing at 100°C and a pressure of 0.8 MPa for 20 seconds.

[0237] After peeling the substrate PET film from the obtained uncured laminated sample A, the curable resin composition was cured under the curing conditions of 170° C. and 30 minutes to obtain a semi-cured laminated sample.

[0238] (2) Formation of guide holes (through holes)

[0239] Use CO 2 A laser (manufactured by Hitachi Via Mechanics Co., Ltd.) is used to form a guide hole (through hole) with a diameter of 60 μm at the upper end and 40 μm at the lower end (bottom) on the obtained semi-cured laminated sample, thereby obtaining a laminate B in which a semi-cured material of a curable resin composition is laminated on a CCL substrate and a guide hole (through hole) is formed on the semi-cured material of the curable resin composition.

[0240] (3) Removal of residue from the bottom of the guide hole

[0241] (a) Swelling treatment

[0242] The obtained laminate B was placed in a swelling liquid (“Swelling Dip Securigant P” manufactured by Atotech Japan Co., Ltd.) at 70° C. and shaken for 10 minutes, and then washed with pure water.

[0243] (b) Permanganate treatment (roughening and desmearing treatment)

[0244] The swollen laminate B was placed in a roughening aqueous solution of potassium permanganate (“Concentrate compact CP” manufactured by Atotech Japan) at 80°C and shaken for 30 minutes. Then, it was treated with a cleaning solution (“Reduction Securigant P” manufactured by Atotech Japan) at 25°C for 2 minutes and then washed with pure water to obtain Evaluation Sample 1.

[0245] The bottom of the guide hole of Evaluation Sample 1 was observed using a scanning electron microscope (SEM), and the maximum smear length from the wall surface of the guide hole bottom was measured.

[0246] The case where the maximum smear length is less than 2 μm is recorded as "◎", the case where the maximum smear length is greater than 2 μm and less than 2.5 μm is recorded as "○", the case where the maximum smear length is greater than 2.5 μm and less than 3 μm is recorded as "△", and the case where the maximum smear length is greater than 3 μm is recorded as "×" to evaluate the smear removal property (the removal property of the residue at the bottom of the guide hole).

[0247] (Plating Adhesion)

[0248] The semi-cured laminate sample prepared in the same manner as in the above "(Removability of smear (Removability of residue at the bottom of the guide hole))" was placed in a 70°C swelling solution (aqueous solution prepared from "Swelling Dip Securigant P" manufactured by Atotech Japan and sodium hydroxide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)) and shaken for 10 minutes. Then, it was washed with pure water.

[0249] The semi-cured laminated sample that had been swollen was placed in an 80°C sodium permanganate roughening aqueous solution (aqueous solution prepared from "Concentratecompact CP" manufactured by Atotech Japan and sodium hydroxide (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)) and shaken for 30 minutes. Then, after cleaning with a 25°C cleaning solution (aqueous solution prepared from "Reduction Securigant P" manufactured by Atotech Japan and sulfuric acid (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)) for 2 minutes, it was further cleaned with pure water to form a roughened semi-cured product on the CCL substrate.

[0250] The surface of the roughened semi-cured product was treated with an alkaline cleaner (manufactured by Atotech Japan, "Cleaner Securigant 902") at 60°C for 5 minutes for degreasing and cleaning. After cleaning, the semi-cured product was treated with a pre-dip solution (manufactured by Atotech Japan, "Predip Neogant B") at 25°C for 2 minutes. Then, the semi-cured product was treated with an activator solution (manufactured by Atotech Japan, "Activator Neogant 834") at 40°C for 5 minutes to allow the palladium catalyst to adhere.

[0251] Next, the semi-cured product was treated with a 30°C reducing solution (Atotech Japan, "Reducer Neogant WA") for 5 minutes and then placed in a chemical copper solution (all Atotech Japan, "Basic PrintgantMSK-DK", "Copper PrintRant MSK", "Stabilizer PrintRant MSK", "Reducer Cu"). Electroless plating was performed until the plating thickness reached about 0.5 μm. After electroless plating, annealing was performed at 120°C for 30 minutes to remove residual hydrogen. All steps until the electroless plating step were performed by setting the treatment solution to 2 L on a beaker scale while shaking the semi-cured product.

[0252] The semi-cured product treated with electroless plating was subjected to electrolytic plating. For electrolytic plating, a copper sulfate solution (an aqueous solution prepared from copper sulfate pentahydrate (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.), sulfuric acid (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.), "Basic Leveler Capacaside HL" manufactured by Atotech Japan, and "Calibrator Capraside GS" manufactured by Atotech Japan) was used, and a current of 0.6 A / cm was passed. 2 After electrolytic plating, the semi-cured product was heated at 190° C. for 90 minutes to further cure the semi-cured product, thereby obtaining a cured product having a copper plating layer laminated on the upper surface.

[0253] In the obtained cured product laminated with the copper-plated layer, a 10 mm wide incision was cut on the surface of the copper-plated layer. Then, using a tensile tester (made by Shimadzu Corporation, "AG-5000B"), under the condition of a crosshead speed of 5 mm / min, the adhesion strength (90° peel strength) of the cured product (insulating layer) and the metal layer (copper-plated layer) was measured.

[0254] The case where the peel strength was 0.50 kgf / cm or more was recorded as "◎", the case where the peel strength was 0.45 kgf / cm or more and less than 0.50 kgf / cm was recorded as "○", the case where the peel strength was 0.40 kgf / cm or more and less than 0.45 kgf / cm was recorded as "△", and the case where the peel strength was less than 0.40 kgf / cm was recorded as "×" to evaluate the plating adhesion.

[0255] [Table 1]

[0256]

[0257] Industrial Applicability

[0258] According to the present invention, a benzoxazine compound that can be used for a curable resin composition having excellent flexibility before curing and excellent dielectric properties after curing can be provided. In addition, according to the present invention, a curable resin composition containing the benzoxazine compound, an adhesive, an adhesive film, a cured product, a circuit board, an interlayer insulating material, and a multilayer printed wiring board using the curable resin composition can be provided.

Claims

1. A benzoxazine compound, characterized in that: The molecule contains: a diamine residue having an aliphatic skeleton having 4 or more carbon atoms and / or a triamine residue having an aliphatic skeleton having 4 or more carbon atoms, and a benzoxazine ring. The diamine and / or triamine from which the diamine residue and / or the triamine residue originates are aliphatic diamines and / or aliphatic triamines derived from dimer acid and / or trimer acid, wherein the dimer acid is a dimer of an aliphatic acid having 10 to 30 carbon atoms, and the trimer acid is a trimer of an aliphatic acid having 10 to 30 carbon atoms. The benzoxazine compound has a structure represented by the following formula (1-1) or (1-2), the following formula (2-1) or (2-2), or the following formula (3), In formula (1-1), A is the diamine residue, X and X' are each independently a hydrogen atom or an arbitrary substituent, In formula (1-2), A is the triamine residue, X, X' and X" are each independently a hydrogen atom or any substituent, In formula (2-1), A is the diamine residue, B and B' are each independently an arbitrary organic group, R and R' are each independently a hydrogen atom or an arbitrary substituent, B and each R are optionally bonded to form a ring structure, B' and each R' are optionally bonded to form a ring structure, Y and Y' are each independently a hydrogen atom or an arbitrary substituent, In formula (2-2), A is the triamine residue, B, B' and B" are each independently an arbitrary organic group, R, R' and R" are each independently a hydrogen atom or an arbitrary substituent, B is optionally bonded to each R to form a ring structure, B' is optionally bonded to each R' to form a ring structure, B" is optionally bonded to each R" to form a ring structure, Y, Y' and Y" are each independently a hydrogen atom or an arbitrary substituent, In formula (3), A and A' are each independently the diamine residue, B is an arbitrary organic group, R and R' are each independently a hydrogen atom or an arbitrary substituent, B and R are optionally bonded to form a ring structure, B and R' are optionally bonded to form a ring structure, and X and X' are each independently a hydrogen atom or an arbitrary substituent.

2. The benzoxazine compound according to claim 1, which has a repeating structural unit represented by the following formula (6), the following formula (7) or the following formula (8), In formula (6), A is the diamine residue, Z is a bond or an arbitrary organic group, and a part or all of the hydrogen atoms of the aromatic ring in formula (6) may be substituted by an arbitrary substituent. In formula (7), A is the diamine residue, B and B' are each independently any organic group, R and R' are each independently a hydrogen atom or any substituent, B and R are optionally bonded to form a ring structure, B' and R' are optionally bonded to form a ring structure, W is any organic group, In formula (8), A and A' are each independently the diamine residue, B is an arbitrary organic group, R and R' are each independently a hydrogen atom or an arbitrary substituent, B and R are optionally bonded to form a ring structure, B and R' are optionally bonded to form a ring structure, Z is a bonding bond or an arbitrary organic group, and a part or all of the hydrogen atoms of the aromatic ring in formula (8) are optionally substituted by an arbitrary substituent. 3 . A curable resin composition comprising the benzoxazine compound according to claim 1 . 4 . The curable resin composition according to claim 3 , comprising a curable resin, a curing agent, and the benzoxazine compound according to claim 1 or 2 .

5. The curable resin composition according to claim 4, wherein The curable resin includes at least one selected from epoxy resin, cyanate resin, phenolic resin, imide resin and maleimide resin. 6 . An adhesive comprising the curable resin composition according to claim 3 . 7 . An adhesive film formed using the curable resin composition according to claim 3 .

8. A cured product obtained by curing the curable resin composition according to claim 3, 4 or 5. 9 . A circuit board comprising the cured product according to claim 8 . 10 . An interlayer insulating material comprising the curable resin composition according to claim 3 . 11 . A multilayer printed wiring board comprising a circuit substrate, a plurality of insulating layers arranged on the circuit substrate, and a metal layer arranged between the plurality of insulating layers, wherein the insulating layer comprises a cured product of the interlayer insulating material according to claim 10 .